C1R and glioblastoma: Given C1R's established role in complement activation and immune modulation, our findings suggest that TEFT‐mediated C1R downregulation may have broader implications for tumor immunology, potentially influencing immune cell infiltration and reshaping the immunosuppressive microenvironment characteristic of mesenchymal GBM.